Signature Wealth Management Partners’s Thermo Fisher Scientific TMO Stock Holding History

Signature Wealth Management Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$418K	Sell	851 -10	-1%	-$5.43K	0.21%	77
2025 Q4	$499K	Hold	861	–	–	0.25%	71
2025 Q3	$418K	Hold	861	–	–	0.22%	73
2025 Q2	$349K	Hold	861	–	–	0.2%	74
2025 Q1	$428K	Hold	861	–	–	0.28%	63
2024 Q4	$448K	Hold	861	–	–	0.31%	64
2024 Q3	$533K	Hold	861	–	–	0.39%	54
2024 Q2	$476K	Hold	861	–	–	0.36%	55
2024 Q1	$500K	Sell	861 -3	-0.3%	-$1.68K	0.41%	53
2023 Q4	$459K	Sell	864 -1	-0.1%	-$484	0.4%	53
2023 Q3	$438K	Hold	865	–	–	0.43%	54
2023 Q2	$451K	Hold	865	–	–	0.42%	54
2023 Q1	$498K	Buy	865 +61	+8%	+$34.4K	0.46%	55
2022 Q4	$443K	Sell	804 -100	-11%	-$53K	0.44%	58
2022 Q3	$459K	Buy	904 +4	+0.4%	+$2.24K	0.51%	54
2022 Q2	$489K	Hold	900	–	–	0.5%	54
2022 Q1	$532K	Sell	900 -200	-18%	-$115K	0.45%	58
2021 Q4	$734K	Buy	1,100 +195	+22%	+$122K	0.62%	41
2021 Q3	$517K	Buy	905 +105	+13%	+$57.6K	0.47%	56
2021 Q2	$404K	Hold	800	–	–	0.37%	62
2021 Q1	$365K	Hold	800	–	–	0.35%	68
2020 Q4	$373K	Buy	+800	New	+$375K	0.37%	62

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Signature Wealth Management Partners's TMO Position: Q1 2026 in Review

Signature Wealth Management Partners reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, selling an estimated $5.43K and leaving 851 shares worth $418K. The position accounts for 0.21% of the portfolio, ranked #77.

Signature Wealth Management Partners first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $734K in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Signature Wealth Management Partners held 851 shares of Thermo Fisher Scientific worth $418K as of Q1 2026.
Signature Wealth Management Partners sold 10 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.43K.
Thermo Fisher Scientific made up 0.21% of Signature Wealth Management Partners's portfolio in Q1 2026, its #77 holding.
Signature Wealth Management Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
Signature Wealth Management Partners's Thermo Fisher Scientific position peaked at $734K in Q4 2021.
2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Signature Wealth Management Partners's 13F filing for Q1 2026, filed 21 Apr 2026.